Advances in metastatic non small cell lung cancer
21 Oct 2018
Advances in metastatic non small cell lung cancer
Comment on the JAVELIN study: RCC immunotherapy
Use of T-VEC in early metastatic melanoma
KEYNOTE 10: Pembrolizumab vs docetaxel for NSCLC
Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial carcinoma
The past, present and future of treating ovarian cancer
Comment on SOLO-1 for advanced ovarian cancer
Olaparib improves progression free survival up front in ovarian cancer
A novel bifunctional fusion protein for combatting lung cancer
Comment on new treatment options for breast cancer
Early stage trials in immunotherapy and brain screening
Results from the PALOMA-3 trial for advanced breast cancer